288 related articles for article (PubMed ID: 33172973)
1. Lysosomal Biogenesis and Implications for Hydroxychloroquine Disposition.
Collins KP; Witta S; Coy JW; Pang Y; Gustafson DL
J Pharmacol Exp Ther; 2021 Feb; 376(2):294-305. PubMed ID: 33172973
[TBL] [Abstract][Full Text] [Related]
2. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
[TBL] [Abstract][Full Text] [Related]
3. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal Fusion: An Efficient Mechanism Increasing Their Sequestration Capacity for Weak Base Drugs without Apparent Lysosomal Biogenesis.
Skoupa N; Dolezel P; Mlejnek P
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947839
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.
Zhitomirsky B; Assaraf YG
Oncotarget; 2015 Jan; 6(2):1143-56. PubMed ID: 25544758
[TBL] [Abstract][Full Text] [Related]
6. MiT/TFE family members suppress L-leucyl-L-leucine methyl ester-induced cell death.
Yabuki A; Miyara M; Umeda-Miyara K; Takao S; Sanoh S; Kotake Y
J Toxicol Sci; 2021; 46(3):143-156. PubMed ID: 33642520
[TBL] [Abstract][Full Text] [Related]
7. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.
Chandra S; Jana M; Pahan K
J Neurosci; 2018 Jul; 38(30):6682-6699. PubMed ID: 29967008
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
Li Y; Cao F; Li M; Li P; Yu Y; Xiang L; Xu T; Lei J; Tai YY; Zhu J; Yang B; Jiang Y; Zhang X; Duo L; Chen P; Yu X
J Exp Clin Cancer Res; 2018 Oct; 37(1):259. PubMed ID: 30373678
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.
Chiang G; Sassaroli M; Louie M; Chen H; Stecher VJ; Sperber K
Clin Ther; 1996; 18(6):1080-92. PubMed ID: 9001825
[TBL] [Abstract][Full Text] [Related]
11. Enhancing lysosomal biogenesis and autophagic flux by activating the transcription factor EB protects against cadmium-induced neurotoxicity.
Pi H; Li M; Tian L; Yang Z; Yu Z; Zhou Z
Sci Rep; 2017 Feb; 7():43466. PubMed ID: 28240313
[TBL] [Abstract][Full Text] [Related]
12. A stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38.
Yang C; Zhu Z; Tong BC; Iyaswamy A; Xie WJ; Zhu Y; Sreenivasmurthy SG; Senthilkumar K; Cheung KH; Song JX; Zhang HJ; Li M
Redox Biol; 2020 May; 32():101445. PubMed ID: 32037305
[TBL] [Abstract][Full Text] [Related]
13. Prevention of crystalline silica-induced inflammation by the anti-malarial hydroxychloroquine.
Burmeister R; Rhoderick JF; Holian A
Inhal Toxicol; 2019 Jun; 31(7):274-284. PubMed ID: 31556748
[No Abstract] [Full Text] [Related]
14. Lysosome biogenesis in health and disease.
Bajaj L; Lotfi P; Pal R; Ronza AD; Sharma J; Sardiello M
J Neurochem; 2019 Mar; 148(5):573-589. PubMed ID: 30092616
[TBL] [Abstract][Full Text] [Related]
15. Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells.
Scheidemann ER; Demas DM; Hou C; Ma J; He W; Sharma G; Schultz E; Weilbaecher KN; Shajahan-Haq AN
Mol Carcinog; 2024 Feb; 63(2):209-223. PubMed ID: 37818798
[TBL] [Abstract][Full Text] [Related]
16. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
[TBL] [Abstract][Full Text] [Related]
17. ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.
Piao S; Ojha R; Rebecca VW; Samanta A; Ma XH; Mcafee Q; Nicastri MC; Buckley M; Brown E; Winkler JD; Gimotty PA; Amaravadi RK
Autophagy; 2017; 13(12):2056-2071. PubMed ID: 28981387
[TBL] [Abstract][Full Text] [Related]
18. Multistep regulation of TFEB by MTORC1.
Vega-Rubin-de-Celis S; Peña-Llopis S; Konda M; Brugarolas J
Autophagy; 2017 Mar; 13(3):464-472. PubMed ID: 28055300
[TBL] [Abstract][Full Text] [Related]
19. Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy.
Guo H; Pu M; Tai Y; Chen Y; Lu H; Qiao J; Wang G; Chen J; Qi X; Huang R; Tao Z; Ren J
Cell Death Differ; 2021 Jan; 28(1):320-336. PubMed ID: 32764647
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal sequestration of weak base drugs, lysosomal biogenesis, and cell cycle alteration.
Mlejnek P; Havlasek J; Pastvova N; Dolezel P; Dostalova K
Biomed Pharmacother; 2022 Sep; 153():113328. PubMed ID: 35785701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
